Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel and Bryostatin-1 in Advanced Pancreatic Cancer
NCT00031694Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2002
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bryostatin-1 in pancreatic cancer (PC), sponsored by National Cancer Institute. Primary endpoint: Response Rate up to 8 years. Started Mar 2002; status: completed.
02
Drugs
bryostatin-1
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00031694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00031694.